isn't nevaxar further behind though?
Phase 3 trials have not commenced for it yet.
Also considering Bayer could effectively buy into this technology and own the only 2 post risection liver cancer drugs, I would not discount this yet.
Charts are looking bearish bigtime.....
I reckon that extremely price sensitive announcements are coming out this half and it is a good time to capitalise.
Won't be buying yet.....but soon.
TheGimp
broker report says sell with valuation 1.50, page-2
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $71.64M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 44.0¢ | 43.5¢ | $72.88K | 167.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 891243 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 95406 | 2 |
View Market Depth
| Last trade - 15.47pm 21/06/2024 (20 minute delay) ? |
| PGL (ASX) Chart |